Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin-Reference-Cited by-同舟云学术

Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin

Published:2009-08 Issue:4 Volume:29 Page:443-449
ISSN:0919-6544
Container-title:Neuropathology
language:en
Short-container-title:

Author:

Park Chul-Kee,Park Sung-Hye,Lee Se-Hoon,Kim Chae-Yong,Kim Dong-Wan,Paek Sun Ha,Kim Dong Gyu,Heo Dae Seog,Kim Il Han,Jung Hee-Won

Publisher

Wiley

Subject

Clinical Neurology,General Medicine,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1789.2008.00998.x/fullpdf

Reference38 articles.

1. Mammalian o6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents;Pegg;Cancer Research,1990

2. Predictive and prognostic markers in neuro-oncology;van den Bent;J Neuropathol Exp Neurol,2007

3. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents;Esteller;N Engl J Med,2000

4. MGMT gene silencing and benefit from temozolomide in glioblastoma;Hegi;N Engl J Med,2005

5. Immunohistochemical study for O6-methylguanine-DNA methyltransferase in the non-neoplastic and neoplastic components of gliomas;Nakasu;J Neuro-Oncol,2004

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?;Nanomaterials;2023-05-12

2. The Impact of IDH1 Mutation and MGMT Promoter Methylation on Recurrence-Free Interval in Glioblastoma Patients Treated With Radiotherapy and Chemotherapeutic Agents;Pathology and Oncology Research;2021-04-29

3. The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas;Acta Neuropathologica Communications;2019-10-17

4. Prognostic significance of O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation and isocitrate dehydrogenase-1 (IDH-1) mutation in glioblastoma multiforme patients: A single-center experience in the Middle East region;Clinical Neurology and Neurosurgery;2019-07

5. IncreasedLGALS3expression independently predicts shorter overall survival in patients with the proneural subtype of glioblastoma;Cancer Medicine;2019-03-07